In Study, Almost Half of Obese Teens Were No Longer So After Taking Wegovy/Ozempic
MONDAY, July 10, 2023 (HealthDay News) — The drugs Wegovy and Ozempic are all the rage for weight loss these days, and now a new study shows these injections may be game-changers for obese teenagers, too.This trial, funded by drug maker Novo Nordisk,…
Learn More¿Toma Ozempic o Wegovy? Pare antes de una cirugía, aconsejan anestesiólogos
LUNES, 3 de julio de 2023 (HealthDay News) — Ozempic, el medicamento de moda para perder peso, podría ser peligroso para un paciente que se somete a anestesia para una cirugía, según una nueva advertencia de la Sociedad Americana de Anestesiólogos (A…
Learn MoreTaking Ozempic, Wegovy? Stop Before Surgery, Anesthesiologists Say
MONDAY, July 3, 2023 (HealthDay News) — The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists.Semaglutide (Ozempic, Wegov…
Learn MoreADA: Reductions in Body Weight With Retatrutide for Obesity
THURSDAY, June 29, 2023 (HealthDay News) — Retatrutide treatment for 48 weeks yields substantial reductions in body weight among adults with obesity, according to a study published online June 26 in the New England Journal of Medicine to coincide wit…
Learn MoreExercise + Weight Loss Perfect Combo to Fight Diabetes
THURSDAY, June 29, 2023 (HealthDay News) — Pairing exercise with a 10% weight loss can make a major health improvement in people living with obesity and prediabetes, a new study says.Building in regular exercise more than doubled sensitivity to insul…
Learn MoreUn nuevo rival de Wegovy se muestra promisorio en ensayos clínicos
MARTES, 27 de junio de 2023 (HealthDay News) — Un medicamento experimental parece funcionar mejor que los medicamentos de moda, Wegovy y Ozempic, tanto para perder peso como para controlar la diabetes, muestran dos ensayos clínicos iniciales. La reta…
Learn MoreUnos nuevos fármacos para perder peso se preparan para competir con Ozempic y Wegovy
LUNES, 26 de junio de 2023 (HealthDay News) — Después de que la compañía farmacéutica Novo Nordisk modificara su medicamento Ozempic para convertirlo en Wegovy, una formulación diseñada de forma expresa para ayudar a los usuarios a bajar de peso, las…
Learn MoreADA: Once-Weekly Tirzepatide Leads to Weight Loss in Patients With Obesity, T2D
TUESDAY, June 27, 2023 (HealthDay News) — Once-weekly tirzepatide provides substantial and clinically meaningful reductions in body weight in adults with obesity and type 2 diabetes, according to a study published online June 26 in the The Lancet to …
Learn MoreADA: Once-Daily Semaglutide Superior for Reduction in Body Weight
TUESDAY, June 27, 2023 (HealthDay News) — Oral semaglutide 50 mg once daily leads to a superior and clinically meaningful reduction in body weight for adults with overweight or obesity without type 2 diabetes, according to a study published online Ju…
Learn More